The smart Trick of ABBV-744 preclinical studies and results That Nobody is Discussing
These side effects were notably milder compared to an inhibitor of both equally bromodomains. An in depth molecular analysis also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor88 These preclinical studies give paradigms for upcoming clinical trials in AML, and the use